Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04023123 · ClinicalTrials.gov registry record
Anterior Corneal Striae in Hypotony
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 98
- Enrollment target
NCT04023123: Completed study, sponsored by Duke University.
NCT04023123 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04023123 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
The goal of this is to evaluate the biomechanical properties of hypotonous eyes with vertical anterior corneal striae and/or hypotony maculopathy compared to hypotonous eyes without striae.
Primary Outcome
Difference in postoperative corneal hysteresis (measured in mm Hg) by Ocular Response Analyzer, between study arms
Interventions
- OTHER Ophthalmic imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2019-09-17 |
| Est. Completion | 2020-03-23 |
What the finished NCT04023123 record still lists
NCT04023123 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Ophthalmic imaging is the first listed.
NCT04023123 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04023123 about?
NCT04023123 is a clinical study titled "Anterior Corneal Striae in Hypotony". The goal of this is to evaluate the biomechanical properties of hypotonous eyes with vertical anterior corneal striae and/or hypotony maculopathy compared to hypotonous eyes without striae.
What is the current status of trial NCT04023123?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2019-09-17. Estimated completion is 2020-03-23.
What interventions are being tested in trial NCT04023123?
The interventions under investigation include: Ophthalmic imaging (OTHER).
Who is sponsoring clinical trial NCT04023123?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI